Postmolar choriocarcinoma with solitary renal metastasis in the absence of primary uterine tumor: A case report and review of the literature

Author:

Geravandi Mahsa1,Hajihashemi Ali1,Adibi Atoosa1,Tirtashi Reza Habibi2

Affiliation:

1. Isfahan University of Medical Sciences

2. Golestan University of Medical Sciences

Abstract

Abstract Background: Choriocarcinoma is a rare high malignant type of gestational trophoblastic disease (GTD) that occurs after pregnancies, abortions, or hydatiform moles and seldom metastasizes to the kidneys. Postmolar choriocarcinoma with renal metastasis is also scarce and was not frequently described. Here, we depicted the first case of postmolar choriocarcinoma with solitary kidney metastasis presenting with spontaneous renal hemorrhage (SRH) in the absence of a primary uterine tumor. Case presentation: A 41-year-old female patient with a history of complete molar pregnancy was evaluated due to severe flank pain, nausea/vomiting, gross hematuria, and vaginal bleeding in the last three weeks. The evaluations demonstrated bilateral pleural effusion without any lesion within the lungs, an empty uterine cavity, and a left kidney lower pole lesion with active bleeding surrounded by hematoma, alongside a serum β-hCG level of 60,000 mIU/mL. According to these findings, laparotomy exploration was planned and ended with a partial nephrectomy, para ovarian cystectomy. In addition, endometrial curettage was performed. The histopathology results revealed choriocarcinoma renal metastasis with high expression of β-hCG, cytokeratin, cytokeratin7, and KI67. In addition, a corpus luteum cyst was found within the left ovarian cyst, and endometrial curettage showed a progestin agent effect without malignant cells. Moreover, the brain, liver, and adrenal glands were not involved with metastases, and the pleural effusion fluid was free of malignant cells. Finally, the patient was referred to the oncology department to receive chemotherapy, and the β-hCG level dropped to 5 mIU/mL after receiving courses of a standard EMA-CO regimen (etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine/oncovin) over three weeks. Conclusions: Postmolar metastatic choriocarcinoma might present only urologic symptoms, such as hematuria and SRH, due to metastatic renal involvement. Indeed, considering choriocarcinoma and evaluating the serum β-hCG level among childbearing-aged females with unexplained urological symptoms could be advantageous, particularly when a previous molar pregnancy exists.

Publisher

Research Square Platform LLC

Reference16 articles.

1. Update on the diagnosis and management of gestational trophoblastic disease;Ngan HY;Int J Gynecol Obstet,2018

2. Metastatic gestational trophoblastic tumour presenting as spontaneous subcapsular renal haematoma;Vijay R;Br J Radiol,2008

3. Metastatic choriocarcinoma presenting as renal colic and skin lesion–case report;Pietrus M;Wiad Lek,2021

4. Case Report: 18F-FDG PET/CT and Laparoscopic Nephron Sparing Surgery in the Management of Bleeding From Renal Metastases of Choriocarcinoma;Du Y;Front Oncol,2022

5. Bilateral renal choriocarcinoma in a postmenopausal woman;Karadeniz T;Korean J Urol,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3